|
Real-time Estimate
Cboe Europe
06:27:30 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 359.10 CHF | +0.93% |
|
-2.72% | +6.86% |
| 09-13 | Roche Outlines Positive Phase 3 Trial Data for Small-cell Lung Cancer Treatment in China | MT |
| 09-11 | Scholar Rock gets first FDA nod for rare muscle-wasting disease (September 11) | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.61% | -3.43% | -0.57% | -5.85% | +6.34% | +36.07% | +115.04% | +408.27% | +1,309.01% | 1,019B | |
| -1.02% | -5.60% | -6.98% | -2.66% | +23.72% | +35.72% | +64.63% | +60.80% | +115.48% | 617B | |
| +1.11% | -0.58% | +2.48% | +0.67% | +15.02% | +12.36% | +77.95% | +141.72% | +317.17% | 464B | |
| +0.34% | -3.01% | -4.01% | +11.38% | +37.09% | +61.79% | +41.24% | +73.65% | +131.03% | 356B | |
| +1.06% | -1.80% | -1.30% | +5.18% | +6.34% | +21.01% | +41.47% | +0.74% | +44.99% | 333B | |
| +1.05% | -3.13% | -6.26% | -6.00% | +7.30% | +11.15% | +34.82% | +54.74% | +52.33% | 267B | |
| +0.13% | -4.85% | -1.29% | -15.70% | -13.81% | -6.60% | +9.03% | +34.22% | +135.74% | 244B | |
| -1.04% | -2.79% | -7.82% | +7.72% | +23.14% | +35.30% | +51.84% | +90.62% | +140.55% | 218B | |
| -1.87% | -4.10% | -4.14% | +10.26% | +17.92% | +28.44% | +93.66% | +114.24% | +87.39% | 179B | |
| -1.11% | -2.48% | -17.71% | -23.39% | -24.37% | -36.36% | -61.31% | -21.47% | +77.17% | 166B | |
| -1.14% | -3.03% | -2.28% | +14.31% | +11.65% | +1.57% | -16.54% | -34.46% | -17.56% | 158B | |
| -0.40% | -4.08% | -7.58% | -4.41% | +11.33% | +25.15% | +43.00% | +184.52% | +484.04% | 128B | |
| -0.50% | -2.72% | -8.49% | +5.20% | +13.37% | +34.54% | +7.79% | +3.77% | +10.76% | 125B | |
| +0.38% | +4.11% | -0.63% | +14.75% | +10.00% | +22.25% | +104.12% | +351.23% | +444.66% | 105B | |
| +0.97% | -0.65% | -5.50% | -4.00% | -13.53% | -16.61% | -30.46% | -14.29% | +4.06% | 95.48B | |
| -0.22% | -4.51% | -3.34% | -10.43% | -2.65% | +9.91% | +19.77% | +2.37% | -15.87% | 94.34B | |
| +0.57% | -4.46% | +30.55% | +138.23% | +544.32% | +566.94% | +82.25% | -41.69% | - | 75.86B | |
| +0.05% | -6.71% | -11.18% | +12.37% | -4.75% | +22.53% | -9.79% | +32.37% | +85.10% | 73.41B | |
| -1.08% | -2.35% | +0.07% | -5.32% | +10.28% | +12.48% | -12.52% | -27.47% | +40.76% | 66.99B | |
| Average | -0.17% | -2.86% | -2.95% | +7.49% | +35.72% | +46.19% | +34.52% | +74.41% | +191.49% | 251.87B | |
| Weighted average by Cap. | -0.02% | -3.24% | -3.08% | +1.31% | +19.29% | +32.73% | +56.35% | +137.31% | +389.61% |
- Stock Market
- Stocks
- ROP Stock
- RO Stock
- Sector Roche Holding AG
Select your edition
All financial news and data tailored to specific country editions
